Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 6,914 | 6,011 | 5,945 | 10,700 | 1,491 |
| Gross Profit | 6,914 | 6,011 | 5,945 | 10,700 | 1,491 |
| Operating Expenses | 64,720 | 150,085 | 95,725 | 121,630 | 493,130 |
| Operating Income | -57,806 | -144,074 | -89,780 | -110,930 | -491,639 |
| Interest Expense | 4,011 | 2,108 | 226 | 261 | 0 |
| Other Income | -1,928 | -20,197 | 28,664 | 2,458 | 2,473 |
| Pre-tax Income | -63,745 | -166,379 | -61,342 | -108,733 | -489,166 |
| Income Tax | N/A | -12,656 | -4,282 | -24,320 | -105,002 |
| Net Income Continuous | -63,745 | -153,723 | -57,060 | -84,413 | -384,164 |
| Net Income | $-63,745 | $-153,723 | $-57,060 | $-84,413 | $-384,164 |
| EPS Basic Total Ops | -1.00 | -2.89 | -1.21 | -1.56 | -7.24 |
| EPS Basic Continuous Ops | -0.84 | -2.69 | -1.03 | -1.54 | -7.24 |
| EPS Diluted Total Ops | -1.00 | -2.89 | -1.21 | -1.56 | -7.24 |
| EPS Diluted Continuous Ops | -0.84 | -2.69 | -1.03 | -1.54 | -7.24 |
| EPS Diluted Before Non-Recurring Items | -1.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-55,828 | $-75,739 | $-72,788 | $-68,105 | $-99,200 |